The objective of the fund is to achieve absolute returns through targeted investment strategies independent of United Kingdom market conditions or indices.
Name | % Net Assets |
---|---|
Elementis | 5.6% |
Glaxosmithkline Ord Gbp0.25 | 4.4% |
Omega Insurance Hl Com Stk Usd0.10 | 4.4% |
Filtrona Ord Gbp0.25 | 4.3% |
Booker Group Ord Gbp0.01 | 3.9% |
Xaar Ord Gbp0.10 | 3.7% |
Johnson Service Gp Ord Gbp0.10 | 3.6% |
Hansteen Hldgs Ord Gbp0.10 | 3.3% |
Menzies(John) Ord Gbp0.25 | 3.3% |
Scapa Group Ord Gbp0.05 | 3.0% |
Key | % Net Assets |
---|---|
Elementis | 5.6% |
Glaxosmithkline Ord Gbp0.25 | 4.4% |
Omega Insurance Hl Com Stk Usd0.10 | 4.4% |
Filtrona Ord Gbp0.25 | 4.3% |
Other | 81.3% |
Date | 21-Nov-2024 |
---|---|
NAV | 211.00p |
Currency | GBP |
Change | 0.50p |
% | 0.24% |
YTD change | 9.10p |
YTD % | 4.51% |
Fund Inception | 07/09/2009 |
---|---|
Fund Manager | n/a |
TER | 1.67 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research